Arca
Skip to content
Tools
Tools

CA2: Carbonic anhydrase 2

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

Catalyzes the reversible hydration of carbon dioxide.

  • Drugs that act on it: 7
  • Approved: 6
  • In phases 1 to 3: 1
  • Sponsors: 7

Who Is On It, and How Far Along

Every drug ChEMBL records acting on CA2, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule

Approved6

  • Acetazolamide
  • Topiramate
  • Dorzolamide
  • Brinzolamide
  • Methazolamide
  • Dichlorphenamide

Phase 31

  • Polmacoxib

Phase 20

    Phase 10

      Sponsors

      Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.

      • CrystalGenomics, Inc.114%
      • Incannex Healthcare Ltd114%

      Modalities

      Drugs on this target by ChEMBL molecule type.

      • Small molecule7100%

      The Landscape

      Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. All act as: Carbonic anhydrase II inhibitor.
      AcetazolamideApprovedIncannex Healthcare LtdSmall moleculeInhibitor—43Boxed warning
      TopiramateApprovedJohnson & JohnsonSmall moleculeInhibitor—31—
      DorzolamideApprovedMerck & Co. (MSD)Small moleculeInhibitor—5—
      BrinzolamideApprovedSandozSmall moleculeInhibitor—2—
      MethazolamideApprovedPfizerSmall moleculeInhibitor—1—
      DichlorphenamideApprovedXeris PharmaceuticalsSmall moleculeInhibitor—0—
      PolmacoxibPhase 3CrystalGenomics, Inc.Small moleculeInhibitor—0—

      Open Trials

      The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 21 in all, from ClinicalTrials.gov.
      Natriuresis With Acetazolamide or SGLT2 Inhibitors Added to Intravenous Loop Diuretics in Decompensated Heart FailureAcetazolamidePhase 4Active, not recruitingUniversidade do Porto2026-11-09
      Adding Acetazolamide on Top of SGLT2 Inhibition in Persons With Type 2 DiabetesAcetazolamidePhase 2Not yet recruitingUniversity Health Network, Toronto2026-10-29
      Comparing Different Medication Regimens to Maintaining Weight Loss Among Adults With Obesity Using GLP-1sTopiramatePhase 4Not yet recruitingJing Luo2026-09-21
      Discontinuing Psychotropic Medication Before Psychotherapy for PTSDTopiramate—Not yet recruitingAcademic Centre for Dentistry in Amsterdam2026-09-03
      Obesity Treatment With Phentermine-Topiramate ER in AYA Surviving Leukemia and LymphomaTopiramatePhase 2Not yet recruitingSt. Jude Children's Research Hospital2026-08-27
      ACetazolamide in Patients With Heart Failure, to Decrease Weight and relIEVE Symptoms.AcetazolamidePhase 3Not yet recruitingUniversity Hospital, Montpellier2026-07-30
      Pragmatic Trial to Study the Cost-Effectiveness of MyPhenome-RX Test to Guide Anti-Obesity PharmacotherapyTopiramateNot applicableNot yet recruitingPhenomix Sciences2026-07-27
      Idiopathic Intracranial Hypertension: Prognostic Factors and Multidisciplinary ManagementTopiramate, AcetazolamideNot applicableActive, not recruitingSohag University2026-07-16
      Dorzolamide/Brimonidine/Timolol Impact on Ocular Surface, Glaucoma Progression & Chatbot Follow-up: GLAUCO-TECHDorzolamidePhase 4Active, not recruitingTecnoquimicas2026-07-08
      Comparing Migraine Preventive Therapies vs. Anti-CGRP Therapies for Tinnitus in Patients With Migraine (COMPACT-PM)TopiramatePhase 4Not yet recruitingStanford University2026-06-17
      DReAMzz- Dronabinol and Acetazolamide Medication for Sleep Apnea (ZZ). Dose Confirmation Crossover Study for IHL-42X in Subjects With Obstructive Sleep Apnea.AcetazolamidePhase 2RecruitingIncannex Healthcare Ltd2026-06-09
      Efficacy and Safety of DNN.31.19.026 for Ocular Hypertension or Primary Open-Angle GlaucomaDorzolamidePhase 3Not yet recruitingAche Laboratorios Farmaceuticos S.A.2026-06-01
      TACTIC-HF: Sequential Diuretic Strategies in Ambulatory Worsening Heart FailureAcetazolamidePhase 4Not yet recruitingLucrecia Maria Burgos2026-05-18
      The Role of Acetazolamide in Mitigating Inflammation and Innate Immune Activation at High AltitudeAcetazolamideEarly phase 1Active, not recruitingUniversity of California, Riverside2026-04-08
      Brain Blood Flow and Sugar Transport in Alzheimer's Disease With and Without Diabetes - A Pilot Imaging StudyAcetazolamide—RecruitingCopenhagen University Hospital, Rigshospitalet2026-03-19
      Neurophysiological Effects of Medication Tapering During Treatment With Spinal Cord StimulationTopiramate—RecruitingBrai²n2026-02-17
      Combining Latency Reversing Agents to Address the HIV ReservoirTopiramatePhase 1 / Phase 2Not yet recruitingErasmus Medical Center2026-02-03
      Efficacy and Safety of HUC3-637 in Patients With Primary Open Angle Glaucoma or Ocular HypertensionDorzolamidePhase 3RecruitingHuons Co., Ltd.2026-01-13
      Retinal Ganglion Cell Neuroprotection Under Prostaglandin AnaloguesBrinzolamide, Dorzolamide—Not yet recruitingAssociation for Innovation and Biomedical Research on Light and Image2025-07-20
      Efficacy of Simbrinza and Rocklatan vs Cosopt and LatanoprostBrinzolamide, DorzolamidePhase 4RecruitingPrairie Eye Center2025-03-19
      Use of Methazolamide to Lower Intraocular PressureMethazolamidePhase 4Active, not recruitingUniversity of Colorado, Denver2022-08-11

      Diseases Most Associated With It

      Open Targets association score, 0 to 1; all associations
      Autosomal recessive osteopetrosis 3
      0.82
      Seizure
      0.59
      Altitude sickness
      0.59
      Angle-closure glaucoma
      0.59
      Edema
      0.59
      Alcohol dependence
      0.56

      Genes and Related Targets

      Complexes and families that share a gene with this target
      Genes
      CA2

      Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL205, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-18. Gene name, function (UniProt P00918, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

      Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.